Hemoglobin News and Research RSS Feed - Hemoglobin News and Research

JAK inhibitors may be first effective treatment for people with alopecia areata

JAK inhibitors may be first effective treatment for people with alopecia areata

Seventy-five percent of patients with moderate to severe alopecia areata—an autoimmune disease that causes patchy, and less frequently, total hair loss—had significant hair regrowth after treatment with ruxolitinib, reported researchers from Columbia University Medical Center. By the end of their treatment, average hair regrowth was 92 percent. [More]
New mobile health app may help manage hydroxyurea treatments in sickle cell patients

New mobile health app may help manage hydroxyurea treatments in sickle cell patients

The National Heart, Lung, and Blood Institute, part of the National Institutes of Health, has awarded a 6-year, $4.4 million grant to St. Jude Children's Research Hospital and collaborators to improve the use of prescribed medication by sickle cell patients. [More]
New HemaApp uses smartphone camera to screen for anemia

New HemaApp uses smartphone camera to screen for anemia

In the developing world, anemia -- a blood condition exacerbated by malnutrition or parasitic disease -- is a staggeringly common health problem that often goes undiagnosed. [More]
Groundbreaking research on effects of NIR light could lead to effective treatment for PTSD

Groundbreaking research on effects of NIR light could lead to effective treatment for PTSD

After years of studying the effects of near-infrared light on veterans with post-traumatic stress disorder or traumatic brain injuries, a team led by a University of Texas at Arlington bioengineer has published groundbreaking research in Nature's Scientific Reports that could result in an effective, long-term treatment for brain disorders. [More]
Studies examine effectiveness of nasal sprays in reducing frequency, duration of HHT-related epistaxis

Studies examine effectiveness of nasal sprays in reducing frequency, duration of HHT-related epistaxis

Two studies appearing in the September 6 issue of JAMA examine the effectiveness of nasal sprays to reduce the frequency and duration of nosebleeds caused by hereditary hemorrhagic telangiectasia (HHT), an inherited condition characterized by abnormal blood vessels which are delicate and prone to bleeding. [More]
Study finds tight glycemic control provides no impact on patient-important microvascular outcomes

Study finds tight glycemic control provides no impact on patient-important microvascular outcomes

The glucocentric focus on lowering blood sugar in Type 2 diabetes may have short-circuited development of new diabetes therapies, according to a new paper published by Mayo Clinic researchers in the journal Circulation: Cardiovascular Quality and Outcomes. [More]
HIV-infected adults with MDD more likely to experience heart attack, study shows

HIV-infected adults with MDD more likely to experience heart attack, study shows

Among more than 26,000 human immunodeficiency virus (HIV)-infected adults, those with major depressive disorder (MDD) were more likely to experience a heart attack than those without MDD, according to a study published online by JAMA Cardiology. [More]
Next generation wearables for health monitoring: an interview with Dr Steven LeBoeuf

Next generation wearables for health monitoring: an interview with Dr Steven LeBoeuf

Wearables have proliferated in the marketplace, but there's still a lot of opportunity for growth. One of the ways in which wearables are limited is that people expect their wearables to really measure what they feel is important to be measured [More]
Scientists find new way to use CRISPR gene editing to help fix sickle cell disease

Scientists find new way to use CRISPR gene editing to help fix sickle cell disease

An international team of scientists led by researchers at St. Jude Children's Research Hospital has found a way to use CRISPR gene editing to help fix sickle cell disease and beta-thalassemia in blood cells isolated from patients. [More]
Researchers identify biophysical markers that may help improve treatments for sickle cell disease

Researchers identify biophysical markers that may help improve treatments for sickle cell disease

An interdisciplinary, international group of researchers has found new biophysical markers that could help improve the understanding of treatments for sickle cell disease, a step toward developing better methods for treating the inherited blood disorder that affects an estimated 80,000 to 100,000 Americans each year. [More]
FDA approves new injection to improve blood sugar levels in adults with type 2 diabetes

FDA approves new injection to improve blood sugar levels in adults with type 2 diabetes

The U.S. Food and Drug Administration approved Adlyxin (lixisenatide), a once-daily injection to improve glycemic control (blood sugar levels), along with diet and exercise, in adults with type 2 diabetes. [More]
Male hormones can reverse biological drivers of aging, study shows

Male hormones can reverse biological drivers of aging, study shows

Telomerase, an enzyme naturally found in the human organism, is the closest of all known substances to a "cellular elixir of youth." In a recent study, Brazilian and US researchers show that sex hormones can stimulate production of this enzyme. [More]
Novel biomarkers may offer solution for detecting autologous blood transfusion in athletes

Novel biomarkers may offer solution for detecting autologous blood transfusion in athletes

Increasing oxygen delivery to muscles can help athletes perform better and give them the edge needed to win elite competitions. One of the best ways to increase oxygen supply is through blood manipulation, undergoing a blood transfusion that provides extra red blood cells and boosts oxygen levels. [More]
Critical evaluation of EKF Diagnostics’ Quo-Test analyzer released

Critical evaluation of EKF Diagnostics’ Quo-Test analyzer released

EKF Diagnostics, the global in-vitro diagnostics company, announces the release of a significant critical evaluation of the Quo-Test analyzer carried out by the European Reference Laboratory for Gylcohemoglobin. This new evaluation represents the culmination of several years’ cooperation between EKF Diagnostics and the European Reference Laboratory to produce a world class Point-of-Care-Testing (POCT) HbA1c analyzer. [More]
UCI researchers use new imaging method to measure fat metabolism

UCI researchers use new imaging method to measure fat metabolism

A team from the University of California, Irvine and supported by the National Institute of Biomedical Imaging and Bioengineering has used a new imaging technique to measure how people break down dietary fat into products the cells of their bodies can use. [More]
Liraglutide drug lowers blood sugar levels in diabetic patients taking large doses of insulin

Liraglutide drug lowers blood sugar levels in diabetic patients taking large doses of insulin

When Amy Sweat was 19 years old, while she was in the hospital recovering from surgery, she was diagnosed with Type 2 diabetes. Ms. Sweat was treated for her diabetes, first on oral drugs, then on increasingly larger doses of insulin, but the years went by and she never was able to achieve good blood sugar control. [More]
New method could help detect unconjugated bilirubin in newborn infants

New method could help detect unconjugated bilirubin in newborn infants

A research group led by Project Professor Morioka Ichiro and Assistant Professor Iwatani Sota in collaboration with Doctor Miyawaki Atsushi have clinically proven that a fluorescent protein sourced from Japanese eel muscles can be used to accurately detect unconjugated bilirubin in newborns. [More]
Circulating microRNAs may help predict risk for myocardial infarction

Circulating microRNAs may help predict risk for myocardial infarction

When you visit your general practitioner you can get your blood analyzed for cholesterol and triglycerides, to get an idea of your risk for cardiovascular disease. With additional information about BMI, smoking habits and blood pressure, this can be used to calculate your 10-year risk for cardiovascular disease. [More]
Oral aloe vera use linked to decreases in FBG and hemoglobin A1c

Oral aloe vera use linked to decreases in FBG and hemoglobin A1c

A meta-analysis of studies in people with diabetes and pre-diabetes has shown that oral aloe vera use was associated with significant decreases in both fasting blood glucose (FBG) and hemoglobin A1c (HbA1c). [More]
Experimental lipid-lowering drug improves glucose control in diabetic patients

Experimental lipid-lowering drug improves glucose control in diabetic patients

High triglycerides -- a type of fat, or lipid, in the blood -- increase the risk of heart disease and perhaps type 2 diabetes. For the first time, it has been shown that profoundly lowering triglycerides in diabetics improves their insulin sensitivity over time, which helps them maintain healthy glucose - blood sugar -- levels. [More]
Advertisement
Advertisement